Investor mix
6 investors on record; lead investors include Prospect Venture Partners, Venrock; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Private equity | 1 | 17% |
| Other / undisclosed | 1 | 17% |
Antibody therapeutics and glycan biology research for precision medicine
6 investors on record; lead investors include Prospect Venture Partners, Venrock; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Private equity | 1 | 17% |
| Other / undisclosed | 1 | 17% |